Digital cognitive testing tool with a self-administered assessment for in-clinic or at-home use.
The system is a HIPAA compliant U.S. FDA Class II Medical Device, which has received marketing authorization in multiple additional regulatory jurisdictions around the world. The tests are trusted and widely adopted in academic research and pharmaceutical drug trials.
The Cognigram system is powered by the Cogstate Brief Battery, which has been used in over 1,000 research studies around the world and cited in hundreds of peer-reviewed journal publications.
This battery consists of four tests, where a single playing card stimulus is presented in the center of the device screen. At the presentation of each playing card stimulus, the patient is required to respond either “YES” or “NO”.